vs

Side-by-side financial comparison of Dexcom (DXCM) and Tapestry, Inc. (TPR). Click either name above to swap in a different company.

Tapestry, Inc. is the larger business by last-quarter revenue ($2.5B vs $1.3B, roughly 2.0× Dexcom). Tapestry, Inc. runs the higher net margin — 22.4% vs 21.2%, a 1.2% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 14.0%). Over the past eight quarters, Tapestry, Inc.'s revenue compounded faster (29.9% CAGR vs 12.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Tapestry, Inc. is a leading American multinational luxury fashion holding company. It owns three iconic lifestyle brands: Coach, Kate Spade New York, and Stuart Weitzman, offering premium handbags, apparel, footwear, accessories, and fragrances to global consumers via physical retail stores and e-commerce platforms.

DXCM vs TPR — Head-to-Head

Bigger by revenue
TPR
TPR
2.0× larger
TPR
$2.5B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+7.6% gap
DXCM
21.6%
14.0%
TPR
Higher net margin
TPR
TPR
1.2% more per $
TPR
22.4%
21.2%
DXCM
Faster 2-yr revenue CAGR
TPR
TPR
Annualised
TPR
29.9%
12.0%
DXCM

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
DXCM
DXCM
TPR
TPR
Revenue
$1.3B
$2.5B
Net Profit
$267.3M
$561.3M
Gross Margin
62.9%
75.5%
Operating Margin
25.6%
28.6%
Net Margin
21.2%
22.4%
Revenue YoY
21.6%
14.0%
Net Profit YoY
153.6%
80.8%
EPS (diluted)
$0.67
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
TPR
TPR
Q1 26
$1.3B
Q4 25
$1.3B
$2.5B
Q3 25
$1.2B
$1.7B
Q2 25
$1.2B
$1.7B
Q1 25
$1.0B
$1.6B
Q4 24
$1.1B
$2.2B
Q3 24
$994.2M
$1.5B
Q2 24
$1.0B
$1.6B
Net Profit
DXCM
DXCM
TPR
TPR
Q1 26
$267.3M
Q4 25
$267.3M
$561.3M
Q3 25
$283.8M
$274.8M
Q2 25
$179.8M
$-517.1M
Q1 25
$105.4M
$203.3M
Q4 24
$151.7M
$310.4M
Q3 24
$134.6M
$186.6M
Q2 24
$143.5M
$159.3M
Gross Margin
DXCM
DXCM
TPR
TPR
Q1 26
62.9%
Q4 25
62.9%
75.5%
Q3 25
60.5%
76.3%
Q2 25
59.5%
76.3%
Q1 25
56.9%
76.1%
Q4 24
58.9%
74.4%
Q3 24
59.7%
75.3%
Q2 24
62.4%
74.9%
Operating Margin
DXCM
DXCM
TPR
TPR
Q1 26
25.6%
Q4 25
25.6%
28.6%
Q3 25
20.1%
19.3%
Q2 25
18.4%
-33.9%
Q1 25
12.9%
16.0%
Q4 24
17.0%
22.4%
Q3 24
15.3%
16.7%
Q2 24
15.7%
14.8%
Net Margin
DXCM
DXCM
TPR
TPR
Q1 26
21.2%
Q4 25
21.2%
22.4%
Q3 25
23.5%
16.1%
Q2 25
15.5%
-30.0%
Q1 25
10.2%
12.8%
Q4 24
13.6%
14.1%
Q3 24
13.5%
12.4%
Q2 24
14.3%
10.0%
EPS (diluted)
DXCM
DXCM
TPR
TPR
Q1 26
$0.67
Q4 25
$0.67
$2.68
Q3 25
$0.70
$1.28
Q2 25
$0.45
$-2.30
Q1 25
$0.27
$0.95
Q4 24
$0.37
$1.38
Q3 24
$0.34
$0.79
Q2 24
$0.35
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
TPR
TPR
Cash + ST InvestmentsLiquidity on hand
$917.7M
$1.1B
Total DebtLower is stronger
$2.4B
Stockholders' EquityBook value
$2.7B
$551.2M
Total Assets
$6.3B
$6.5B
Debt / EquityLower = less leverage
4.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
TPR
TPR
Q1 26
$917.7M
Q4 25
$917.7M
$1.1B
Q3 25
$1.8B
$743.2M
Q2 25
$1.2B
$1.1B
Q1 25
$904.9M
$1.1B
Q4 24
$606.1M
$1.0B
Q3 24
$621.2M
$7.3B
Q2 24
$939.2M
$7.2B
Total Debt
DXCM
DXCM
TPR
TPR
Q1 26
Q4 25
$2.4B
Q3 25
$2.4B
Q2 25
$2.4B
Q1 25
$2.4B
Q4 24
$2.4B
Q3 24
$7.0B
Q2 24
$6.9B
Stockholders' Equity
DXCM
DXCM
TPR
TPR
Q1 26
$2.7B
Q4 25
$2.7B
$551.2M
Q3 25
$2.7B
$399.5M
Q2 25
$2.6B
$857.8M
Q1 25
$2.3B
$1.5B
Q4 24
$2.1B
$1.3B
Q3 24
$2.0B
$3.0B
Q2 24
$2.4B
$2.9B
Total Assets
DXCM
DXCM
TPR
TPR
Q1 26
$6.3B
Q4 25
$6.3B
$6.5B
Q3 25
$7.5B
$6.4B
Q2 25
$7.3B
$6.6B
Q1 25
$6.8B
$7.3B
Q4 24
$6.5B
$7.3B
Q3 24
$6.4B
$13.7B
Q2 24
$6.8B
$13.4B
Debt / Equity
DXCM
DXCM
TPR
TPR
Q1 26
Q4 25
4.32×
Q3 25
5.95×
Q2 25
2.77×
Q1 25
1.59×
Q4 24
1.78×
Q3 24
2.35×
Q2 24
2.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
TPR
TPR
Operating Cash FlowLast quarter
$1.1B
Free Cash FlowOCF − Capex
$1.0B
FCF MarginFCF / Revenue
41.5%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$1.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
TPR
TPR
Q1 26
Q4 25
$294.0M
$1.1B
Q3 25
$659.9M
$112.6M
Q2 25
$303.0M
$446.8M
Q1 25
$183.8M
$144.3M
Q4 24
$301.4M
$506.0M
Q3 24
$199.5M
$119.5M
Q2 24
$279.4M
$256.0M
Free Cash Flow
DXCM
DXCM
TPR
TPR
Q1 26
Q4 25
$192.1M
$1.0B
Q3 25
$579.4M
$80.2M
Q2 25
$208.9M
$411.5M
Q1 25
$96.8M
$113.4M
Q4 24
$176.8M
$475.1M
Q3 24
$88.3M
$93.9M
Q2 24
$213.3M
$209.8M
FCF Margin
DXCM
DXCM
TPR
TPR
Q1 26
Q4 25
15.3%
41.5%
Q3 25
47.9%
4.7%
Q2 25
18.1%
23.9%
Q1 25
9.3%
7.2%
Q4 24
15.9%
21.6%
Q3 24
8.9%
6.2%
Q2 24
21.2%
13.2%
Capex Intensity
DXCM
DXCM
TPR
TPR
Q1 26
Q4 25
8.1%
1.7%
Q3 25
6.7%
1.9%
Q2 25
8.1%
2.0%
Q1 25
8.4%
2.0%
Q4 24
11.2%
1.4%
Q3 24
11.2%
1.7%
Q2 24
6.6%
2.9%
Cash Conversion
DXCM
DXCM
TPR
TPR
Q1 26
Q4 25
1.10×
1.93×
Q3 25
2.33×
0.41×
Q2 25
1.69×
Q1 25
1.74×
0.71×
Q4 24
1.99×
1.63×
Q3 24
1.48×
0.64×
Q2 24
1.95×
1.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

TPR
TPR

Coach$1.4B57%
Other$787.0M31%
Kate Spade Company$290.0M12%

Related Comparisons